Procter & Gamble Health Limited (PGHL) - Total Assets

Latest as of September 2025: Rs8.94 Billion INR ≈ $96.73 Million USD

Based on the latest financial reports, Procter & Gamble Health Limited (PGHL) holds total assets worth Rs8.94 Billion INR (≈ $96.73 Million USD) as of September 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. See net assets of Procter & Gamble Health Limited for net asset value and shareholders' equity analysis.

Procter & Gamble Health Limited - Total Assets Trend (2003–2024)

This chart illustrates how Procter & Gamble Health Limited's total assets have evolved over time, based on quarterly financial data.

Procter & Gamble Health Limited - Asset Composition Analysis

Current Asset Composition (December 2024)

Procter & Gamble Health Limited's total assets of Rs8.94 Billion consist of 66.3% current assets and 33.7% non-current assets.

Asset Category	Amount (INR)	% of Total Assets
Cash & Equivalents	Rs898.10 Million	23.7%
Accounts Receivable	Rs1.47 Billion	18.5%
Inventory	Rs1.09 Billion	13.8%
Property, Plant & Equipment	Rs1.22 Billion	15.4%
Intangible Assets	Rs7.10 Million	0.1%
Goodwill	Rs0.00	0.0%

Asset Composition Trend (2003–2024)

This chart illustrates how Procter & Gamble Health Limited's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see Procter & Gamble Health Limited (PGHL) market capitalisation.

Show as percentage

Key Asset Composition Facts

Current vs. Non-Current Assets: Procter & Gamble Health Limited's current assets represent 66.3% of total assets in 2024, an increase from 48.6% in 2003.
Cash Position: Cash and equivalents constituted 23.7% of total assets in 2024, up from 0.3% in 2003.
Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2003.
Asset Diversification: The largest asset category is accounts receivable at 18.5% of total assets.

Procter & Gamble Health Limited Competitors by Total Assets

Key competitors of Procter & Gamble Health Limited based on total assets are shown below.

Company	Country	Total Assets
Daihan Pharmaceutical Co.Ltd KQ:023910	Korea	₩344.02 Billion
Aurobindo Pharma Limited NSE:AUROPHARMA	India	Rs525.46 Billion
China Resources Sanjiu Medical & Pharmaceutical Co Ltd SHE:000999	China	CN¥56.56 Billion
Ningbo Menovo Pharm Co Ltd SHG:603538	China	CN¥4.75 Billion
Zhejiang Xianju Pharmaceutical Co Ltd SHE:002332	China	CN¥7.26 Billion
Qianjiang Yongan Pharmaceutical Co Ltd SHE:002365	China	CN¥2.26 Billion
Zhejiang Cheng Yi Pharmaceutical Co Ltd SHG:603811	China	CN¥1.69 Billion
Hainan Honz Pharmaceutical Co SHE:300086	China	CN¥1.88 Billion

Procter & Gamble Health Limited - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric	Current	1 Year Ago	5 Years Ago
Current Ratio	2.87	3.35	3.59
Quick Ratio	2.30	2.79	2.65
Cash Ratio	1.26	0.00	0.00
Working Capital	Rs4.17 Billion	Rs5.41 Billion	Rs4.24 Billion

Procter & Gamble Health Limited - Advanced Valuation Insights

This section examines the relationship between Procter & Gamble Health Limited's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio	12.80
Latest Market Cap to Assets Ratio	0.12
Asset Growth Rate (YoY)	0.0%
Total Assets	Rs7.94 Billion
Market Capitalization	$936.52 Million USD

Valuation Analysis

Below Book Valuation: The market values Procter & Gamble Health Limited's assets below their book value (0.12x), which may indicate investor concerns about asset quality or future growth.

Slight Asset Contraction: Procter & Gamble Health Limited's assets decreased by 0.0% over the past year, which may reflect streamlining or optimization of resources.

Annual Total Assets for Procter & Gamble Health Limited (2003–2024)

The table below shows the annual total assets of Procter & Gamble Health Limited from 2003 to 2024.

Year	Total Assets	Change
2024-12-31	Rs7.94 Billion ≈ $85.89 Million	-0.02%
2023-12-31	Rs7.94 Billion ≈ $85.91 Million	-27.86%
2022-12-31	Rs11.01 Billion ≈ $119.09 Million	+23.21%
2021-12-31	Rs8.94 Billion ≈ $96.65 Million	-9.37%
2020-12-31	Rs9.86 Billion ≈ $106.65 Million	-16.17%
2019-12-31	Rs11.76 Billion ≈ $127.22 Million	-33.14%
2018-12-31	Rs17.59 Billion ≈ $190.28 Million	+77.50%
2017-12-31	Rs9.91 Billion ≈ $107.20 Million	+12.28%
2016-12-31	Rs8.83 Billion ≈ $95.47 Million	+12.61%
2015-12-31	Rs7.84 Billion ≈ $84.78 Million	+10.70%
2014-12-31	Rs7.08 Billion ≈ $76.59 Million	+9.19%
2013-12-31	Rs6.49 Billion ≈ $70.14 Million	+9.14%
2012-12-31	Rs5.94 Billion ≈ $64.27 Million	+18.94%
2011-12-31	Rs5.00 Billion ≈ $54.03 Million	+16.20%
2010-12-31	Rs4.30 Billion ≈ $46.50 Million	-24.32%
2009-12-31	Rs5.68 Billion ≈ $61.44 Million	+1.36%
2008-12-31	Rs5.61 Billion ≈ $60.62 Million	+14.50%
2007-12-31	Rs4.90 Billion ≈ $52.94 Million	+2.12%
2006-12-31	Rs4.79 Billion ≈ $51.84 Million	+23.73%
2005-12-31	Rs3.87 Billion ≈ $41.90 Million	+18.48%
2004-12-31	Rs3.27 Billion ≈ $35.36 Million	+17.60%
2003-12-31	Rs2.78 Billion ≈ $30.07 Million	--

About Procter & Gamble Health Limited

NSE:PGHL India Drug Manufacturers - Specialty & Generic

Market Cap

$936.52 Million

Rs86.60 Billion INR

Market Cap Rank

#9387 Global

#443 in India

Share Price

Rs5216.90

Change (1 day)

+1.59%

52-Week Range

Rs4778.60 - Rs6581.50

All Time High

Rs6870.36